Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Baxter International (NY:BAX)

23.09 +0.12 (+0.52%)
Official Closing Price Updated: 7:00 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Baxter International

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength... 
Via Benzinga
Baxter and bioMérieux Announce CE Mark for NEPHROCLEAR™ CCL14 Test to Predict Persistent Severe Acute Kidney Injury
From Baxter International Inc. and bioMérieux
Via Business Wire
Stock Profile: Baxter International Inc.
Baxter International reported second-quarter sales increased a healthy 14% to $3.1 billion with net income increasing 22% to $301 million and EPS jumping 23% to $0.59. 
Via Talk Markets
Baxter to Present at Credit Suisse 30th Annual Virtual Healthcare Conference
From Baxter International Inc.
Via Business Wire
Baxter Presents Critical Care Data at 34th Annual European Society of Intensive Care Medicine LIVES Congress
From Baxter International Inc.
Via Business Wire
Baxter to Host Third-Quarter 2021 Financial Results Conference Call for Investors
From Baxter International Inc.
Via Business Wire
Baxter's Norepinephrine Wins FDA Nod For Low Blood Pressure
The FDA has approved Baxter International Inc's (NYSE: BAX) premix norepinephrine bitartrate in 5% dextrose injection. Norepinephrine is indicated to raise blood pressure in... 
Via Benzinga
Baxter Announces U.S. FDA Approval and Launch of Ready-to-use Cardiovascular Medicine Norepinephrine in Premix Formulation
From Baxter International Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2021
Upgrades For Bank of America Corp (NYSE: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 3, 2021
Upgrades Barclays upgraded the previous rating for Baxter International Inc (NYSE: 
Via Benzinga
Price To Earnings Ratio Insights For Baxter Intl
Looking into the current session, Baxter Intl Inc. (NYSE:BAX) shares are trading at $82.22, after a 5.95% rise. Moreover, over the past month, the stock spiked by 10... 
Via Benzinga
Baxter to Acquire Hillrom At $156/Share: See The Highlights
Baxter International Inc (NYSE: BAX) has agreed to acquire Hill-Rom Holdings Inc (NYSE: HRC) for $156.00 per share in cash, slightly higher than the earlier... 
Via Benzinga
Baxter to Acquire Hillrom, Expanding Connected Care and Medical Innovation Globally
From Baxter International Inc.
Via Business Wire
2 Little-Followed Stocks That Are Soaring Monday
Markets were on the rise overall, but these companies were surprising in their gains. 
Via The Motley Fool
Topics Stocks
Why Shares of Hill-Rom Holdings Are Surging This Morning
A previous buyout offer gets raised. 
Via The Motley Fool
Baxter In Advanced Talks For $10B Hill Rom Buyout: WSJ
The Wall Street Journal reported that Baxter International Inc (NYSE: BAX) is reportedly in advanced talks to Hill-Rom Holdings Inc (NYSE: HRC) for... 
Via Benzinga
Baxter International Inc (BAX) Under Pressure, Here’s The Trade
Baxter International Inc stock is now trading below its 200-week moving average. This puts the stock in a weak technical position on the charts and indicates lower stock prices ahead. 
Via Talk Markets
Stocks That Hit 52-Week Lows On Thursday
During Thursday's morning session, 21 companies made new 52-week lows. Interesting Highlights: Baxter Intl (NYSE:BAX) was the largest company by market cap to... 
Via Benzinga
The Baxter International Foundation and UNICEF USA Announce Partnership to Improve Water Security in Colombia
From Baxter International Inc.
Via Business Wire
Baxter Recalls Dose IQ Software 9.0.x Used With Infusion Pumps
The FDA issued a Class I recall, the most serious kind of recall, for Baxter International Inc's (NYSE: BAX) Dose IQ safety software used with Spectrum IQ... 
Via Benzinga
Topics Product Recall
Got $5,000? These 3 Solid Dividend Stocks Are Trading Near Their 52-Week Lows
If you're an income investor, these investments should be on your radar right now. 
Via The Motley Fool
Baxter Advances Enterprise Digital Transformation in Collaboration With AWS
From Baxter International Inc.
Via Business Wire
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (... 
Via Benzinga
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)... 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
During Thursday's morning session, 77 companies made new 52-week lows. Areas of Interest: The largest company in terms of market cap to set a new 52-week low... 
Via Benzinga
Why Hill-Rom Stock Jumped 13% This Week
Earnings are due out tomorrow, but they won't be great. 
Via The Motley Fool
Baxter International Inc (BAX) Q2 2021 Earnings Call Transcript
BAX earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Baxter to Present at UBS Genomics 2.0 and MedTech Innovations Summit
From Baxter International Inc.
Via Business Wire
Baxter Q2 Earnings Marginally Beat Estimates; Revises Upper End Of 2021 EPS Outlook
Baxter International Inc (NYSE: BAX) Q2 revenue of $3.1 billion, in line with the consensus, increased 14% on a reported basis, 9% on a constant currency basis, and 8%... 
Via Benzinga
Baxter Announces Acquisition of PerClot Polysaccharide Hemostatic System to Expand Advanced Surgery Portfolio
From Baxter International Inc.
Via Business Wire
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.